These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 14528507

  • 1. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR.
    J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
    [Abstract] [Full Text] [Related]

  • 2. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R.
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [Abstract] [Full Text] [Related]

  • 3. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC, Lau CS, Lee KW, Wong RW.
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [Abstract] [Full Text] [Related]

  • 4. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A, Cárdenas-Mondragón G.
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [Abstract] [Full Text] [Related]

  • 5. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A.
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [Abstract] [Full Text] [Related]

  • 6. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations.
    El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S.
    J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050
    [Abstract] [Full Text] [Related]

  • 7. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F.
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [Abstract] [Full Text] [Related]

  • 8. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A, Pochopień-Kenig G, Scieszka J.
    Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
    [Abstract] [Full Text] [Related]

  • 9. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y.
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 Apr; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

  • 11. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T, Fierz W, Stoll T, Villiger PM.
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.
    McMurray RW, Weidensaul D, Allen SH, Walker SE.
    J Rheumatol; 1995 Nov; 22(11):2084-91. PubMed ID: 8596149
    [Abstract] [Full Text] [Related]

  • 13. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F.
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [Abstract] [Full Text] [Related]

  • 14. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 15. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
    Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE.
    Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 17. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 18. Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters.
    Muñoz JA, Gil A, López-Dupla JM, Vázquez JJ, González-Gancedo P.
    Ann Med Interne (Paris); 1994 Feb; 145(7):459-63. PubMed ID: 7864512
    [Abstract] [Full Text] [Related]

  • 19. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C, Brühlmann P, Sprott H, Gay RE, Michel BA, Gay S, Neidhart M.
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [Abstract] [Full Text] [Related]

  • 20. Prolactin, dendritic cells, and systemic lupus erythematosus.
    Jara LJ, Benitez G, Medina G.
    Autoimmun Rev; 2008 Jan; 7(3):251-5. PubMed ID: 18190887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.